U.S. Capital Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,022
| Closed | -$168K | – | 1542 |
|
|
2022
Q4 | $168K | Sell |
2,022
-2,797
| -58% | -$232K | 0.01% | 644 |
|
|
2022
Q3 | $382K | Buy |
+4,819
| New | +$382K | 0.02% | 489 |
|
|
2022
Q2 | – | Sell |
-2,470
| Closed | -$222K | – | 739 |
|
|
2022
Q1 | $222K | Buy |
+2,470
| New | +$222K | 0.01% | 653 |
|
|
2021
Q4 | – | Sell |
-27,684
| Closed | -$3.48M | – | 760 |
|
|
2021
Q3 | $3.48M | Buy |
+27,684
| New | +$3.48M | 0.15% | 152 |
|